Sandra M Axiak-Bechtel

6PUBLICATIONS
6CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 07, 2025
Safety, Efficacy and Doxorubicin Pharmacokinetics During Cannabidiol/Cannabidiolic Acid Rich Hemp Oil Use in Dogs With Lymphoma Undergoing CHOP Chemotherapy.

Amandine Lejeune, Sandra Bechtel, Rowan Milner

|Oct 28, 2023
Safety of TCMCB07, a melanocortin-4 antagonist peptide, in dogs with naturally occurring cachexia.

Sandra M Axiak-Bechtel, Stacey B Leach, Jessica R Newton-Northup

|May 20, 2021
Pharmacokinetics and safety of TCMCB07, a melanocortin-4 antagonist peptide in dogs.

Sandra M Axiak-Bechtel, Stacey B Leach, David G Scholten

|Jan 15, 2021
Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Jordan Ayers, Rowan J Milner, Galaxia Cortés-Hinojosa

|Aug 03, 2019
Dogs with osteosarcoma have altered pro- and anti-inflammatory cytokine profiles.

Sandra M Axiak-Bechtel, Leanne M Mathew, Juliana R Amorim

|Sep 02, 2018
Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors.

Cheryl A London, Jaime Acquaviva, Donald L Smith

Pageof 1

Frequent Collaborators

3 joint publications

Rowan Milner

1 joint publications

Galaxia Cortés-Hinojosa

1 joint publications

Amandine Lejeune

1 joint publications

Stacey B Leach